Viking Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $100,827,000.
Profit Margin
| 2014 | 0 | -21.88M | |
|---|---|---|---|
| 2015 | 0 | -23.40M | |
| 2016 | 0 | -14.73M | |
| 2017 | 0 | -20.57M | |
| 2018 | 0 | -22.06M | |
| 2019 | 0 | -25.77M | |
| 2020 | 0 | -36.05M | |
| 2021 | 0 | -54.00M | |
| 2022 | 0 | -67.37M | |
| 2023 | 0 | -85.89M |
VKTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 292K | 291K | 296K | 277K | 260K | 0 | 0 | 0 | 0 | 0 |
Gross profit | -292K | -291K | -296K | -277K | -260K | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 63.80M | 54.23M | 44.98M | 31.93M | 23.55M | 19.04M | 13.74M | 9.00M | 6.96M | 22.22M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 100.82M | 70.35M | 55.68M | 42.66M | 32.68M | 26.16M | 19.07M | 13.84M | 11.99M | 23.46M |
Operating income | -100.82M | -70.35M | -55.68M | -42.66M | -32.68M | -26.16M | -19.07M | -13.84M | -11.99M | -23.46M |
Other income (expenses), net | 14.93M | 1.48M | 692K | 3.16M | 6.90M | 1.38M | -1.50M | 1.06M | -11.40M | 1.58M |
Income before tax | -85.89M | -68.86M | -54.99M | -39.49M | -25.77M | -22.06M | -20.57M | -14.73M | -23.40M | -21.88M |
Income tax expense | 0 | -1.48M | -988K | -3.44M | 0 | -2.71M | 1.85M | 1.94M | 982.18K | 628.67K |
Net income | -85.89M | -67.37M | -54.00M | -36.05M | -25.77M | -22.06M | -20.57M | -14.73M | -23.40M | -21.88M |
Earnings per share | ||||||||||
Basic EPS | -0.91 | -0.88 | -0.7 | -0.5 | -0.36 | -0.38 | -0.79 | -0.9 | -3.68 | -5.08 |
Diluted EPS | -0.91 | -0.88 | -0.7 | -0.5 | -0.36 | -0.38 | -0.79 | -0.9 | -3.68 | -5.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |